FAZ Technology specialises in the research and development of fibre-optic sensing solutions, whose potential is much broader than Fugro’s core markets; hence Fugro’s decision to divest. FAZ Technology’s fibre-optic sensing solutions will complement Optics11 range of unique sensing products, including acoustic emission detection, hydrophone arrays and seismic monitoring, and will enable Optics11 to develop full structural-health monitoring and condition-monitoring solutions.
“We strongly believe that fibre-optic technology has great potential for more and more future applications and are very confident that the best in class FBG sensing technology available on the market today will strengthen our position,” said Optics11 CEO, Niek Rijnveld. “Incorporating Fugro’s FAZ Technology into our existing offering allows us to take a major step towards full integrated fiber optic high-end monitoring solutions,”
Fibre-optic technology provides unmatched sensing capabilities in challenging environments such as extreme temperatures, remote locations and high-radiation environments. Optics11 is best positioned to refine this technology’s evolution, also in close collaboration with Fugro. The two companies have agreed to work together to develop leading-edge solutions for monitoring the structural health of assets such as offshore wind farms and civil infrastructure, including bridges, roads, tunnels and other high-value assets, an increasing number of which are approaching the end of their design life. Insight into the behaviour of these structural assets is essential for their safe and sustainable design, build and maintenance.
+31 20 598 9179
Optics11 is a high-tech company based in Amsterdam and is offering new optical fiber measurement platforms for many different markets with customers all over the world. Our strength is fast and lean product development, which is enabled by our broad range of engineering skills: fiber optics, electronics, software, micromanufacturing, mechanics and mechatronics. Besides our engineering passion, we pride ourselves on always listening to customer needs first and providing added value where it really matters for the users. We believe that optical fiber sensing provides a unique solution for many applications that involve precise measurements in challenging environments.
MedTech startup Sirius Medical has received CE Mark approval for Sirius Pintuition, a non-radioactive device to localize breast tumors. In 2016 Bram Schermers, then a scientist at NKI, pitched an early concept at the annual Amsterdam Science & Innovation Awards and won first prize! His pitch also caught the attention of seasoned entrepreneur Hubert Martens, […]News
An annual survey held by the program directors of the Joint Master Entrepreneurship (UvA/ VU), Bram Kuijken and Enno Masurel, has found that 17.8% of alumni have founded their own company and 11.0% are currently working freelance. Additionally, the study found that 41.9% of alumni is employed by a startup (19.7%) or a scale-up (22.2%). […]News
CimCure, a spin-off of Amsterdam UMC and focusing on cancer immunotherapies for solid tumors, signed a strategic partnership agreement for in-licensing CimCure’s iBoost technology with Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and bacterial vaccines. The iBoost (immune boost) technology was developed at Amsterdam […]News